Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

29.2K
Overview
29.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

678
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
678
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.0K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
Hypersensitivities01:30

Hypersensitivities

1.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.2K
Antibody Structure01:10

Antibody Structure

61.8K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.8K
Cross-reactivity00:42

Cross-reactivity

31.7K
Overview
31.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and molecular improvements in pediatric patients with atopic dermatitis treated with dupilumab: an analysis from the TREATKids registry.

The Journal of investigative dermatology·2026
Same author

<i>Staphylococcus aureus</i> serine protease-like protein B elicits a type 1/type 2 immune response in atopic dermatitis patients.

Frontiers in immunology·2026
Same author

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same author

Digital Dermatology.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Anthropometric patterns in children with moderate-to-severe atopic dermatitis: Cross-sectional insights from the TREATkids cohort.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

A Real-world Meta-analysis Study of Disease Severity in European Patients Who Received Baricitinib for Atopic Dermatitis: Data from BioDay, SCRATCH and TREATgermany.

Acta dermato-venereologica·2026

Related Experiment Video

Updated: Oct 13, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.6K

[Allergen immunotherapy for atopic dermatitis].

Stephan Traidl1, Thomas Werfel2

  • 1Klinik für Dermatologie, Allergologie und Venerologie, Abteilung für Immundermatologie und experimentelle Allergologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. Traidl.Stephan@mh-hannover.de.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|November 18, 2021
PubMed
Summary

Allergen-specific immunotherapy (AIT) is rarely used in atopic dermatitis (AD), but studies suggest a subgroup of patients may benefit. Further research could expand AIT use for AD treatment.

Keywords:
AeroallergensAtopic comorbidityExacerbationHouse dust miteReview

More Related Videos

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

4.1K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K

Related Experiment Videos

Last Updated: Oct 13, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.6K
A Mouse Ear Model for Allergic Contact Dermatitis Evaluation
08:02

A Mouse Ear Model for Allergic Contact Dermatitis Evaluation

Published on: March 24, 2023

4.1K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K

Area of Science:

  • Immunology
  • Dermatology
  • Allergy Research

Background:

  • Allergen-specific immunotherapy (AIT) is a curative treatment for allergies, with extensive research supporting its efficacy.
  • Despite its potential, AIT is infrequently utilized in managing atopic dermatitis (AD), a common skin condition.
  • Aeroallergens are recognized contributors to AD exacerbations, highlighting a potential role for AIT.

Purpose of the Study:

  • To review existing studies, meta-analyses, and guidelines on AIT for atopic dermatitis (AD) patients.
  • To assess the current evidence regarding the effectiveness and application of AIT in AD management.
  • To identify factors influencing the comparability and generalizability of AIT studies in AD.

Main Methods:

  • Systematic review of clinical trials and meta-analyses on AIT in AD.
  • Analysis of current international guideline recommendations for AIT in AD.
  • Evaluation of study designs, allergens, administration routes, endpoints, and patient cohorts.

Main Results:

  • Significant heterogeneity exists across AIT studies in AD regarding design, allergens, and outcomes, complicating direct comparisons.
  • Multiple trials indicate a positive impact of AIT on AD symptoms, suggesting benefit for a subset of patients.
  • Evidence suggests that specific patient subgroups may experience significant improvement with AIT.

Conclusions:

  • AIT shows promise for treating atopic dermatitis (AD), particularly in specific patient populations.
  • The heterogeneity in current research necessitates standardized study designs for clearer AIT efficacy assessment in AD.
  • Future advancements in AIT may lead to its wider adoption and improved management of AD.